Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Jun;64(6):943–946. doi: 10.1136/ard.2004.026377

Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients

R Asherson 1, G Espinosa 1, R Cervera 1, J Gomez-Puerta 1, J Musuruana 1, S Bucciarelli 1, M Ramos-Casals 1, A Martinez-Gonzalez 1, M Ingelmo 1, J Reverter 1, J Font 1, D Triplett 1, t for 1
PMCID: PMC1755506  PMID: 15897312

Abstract

Objective: To analyse the clinical and laboratory characteristics of catastrophic APS patients with DIC features.

Methods: The web site based international registry of patients with catastrophic APS (CAPS registry) (http://www.med.ub.es/MIMMUN/FORUM/CAPS.HTM) was analysed and the cases with DIC features selected.

Results: In 173 patients with catastrophic APS, 23 (13%) were found with DIC features. The clinical and immunological characteristics were similar in catastrophic APS patients with and without DIC features; a significant difference was found only in the prevalence of thrombocytopenia (100% in patients with DIC features v 59% in those without DIC features).

Conclusions: DIC features are not rare in catastrophic APS, supporting the need for systematic screening of antiphospholipid antibodies in all patients with DIC features without precipitating factors. The presence of DIC features in the context of an APS makes it imperative to rule out the catastrophic variant of this syndrome.

Full Text

The Full Text of this article is available as a PDF (71.9 KB).


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES